Search
SpyGlass Pharma Ord shs (Proposed)
SGPAdd to Watchlist
19.150USD
-0.320-1.64%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
611.10MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
5
analysts
Strong Buy
Current Rating
45.000
Target Price
+131.12%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
SpyGlass Pharma Ord shs (Proposed)
SGP
5
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
How have SpyGlass Pharma Ord shs (Proposed)SGP's recent earnings per share performed?
The market expectation was USD -0.69, while SpyGlass Pharma Ord shs (Proposed)SGP's earnings per share (EPS) for the previous quarter was USD -1.25. EPS for the next quarter is expected at USD -0.56.
What is the analyst rating for SpyGlass Pharma Ord shs (Proposed)?
Based on the ratings of SpyGlass Pharma Ord shs (Proposed)'s stock from 5 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.